SCHEMBL20248063

SCHEMBL20248063

O=[N+]([O-])c1cc(S)cc(S(=O)(=O)Cl)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.42
▸ HTT P42858 3/20 0.42
▸ GAA P10253 1/20 0.42
▸ CA2 P00918 6/20 0.40
▸ CA5A P35218 3/20 0.40
▸ ALDH1A1 P00352 2/20 0.39
▸ CYP19A1 P11511 1/20 0.39
▸ CA1 P00915 5/20 0.37
▸ CA12 O43570 3/20 0.37
▸ CA9 Q16790 3/20 0.37
▸ CA14 Q9ULX7 3/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ CA3 P07451 2/20 0.37
▸ CA4 P22748 2/20 0.37
▸ CA6 P23280 2/20 0.37
▸ CA7 P43166 2/20 0.37
▸ CA13 Q8N1Q1 2/20 0.37
▸ CA5B Q9Y2D0 2/20 0.37
▸ LMNA P02545 2/20 0.37
▸ MMP1 P03956 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2214769 0.86 CYP19A1 (0.52) KMT2AHTTGAACA2CA5A
SCHEMBL816810 0.86 HTT (0.48) KMT2AHTTGAACA2CA5A
SCHEMBL2055461 0.79 ALDH1A1 (0.46) KMT2AHTTGAACA2CA5A
SCHEMBL15122462 0.78 KMT2A (0.42) KMT2AHTTGAACA2CA5A
SCHEMBL2820707 0.78 ACP1 (0.43) KMT2AHTTGAACA2CA5A
SCHEMBL11822050 0.77 CYP19A1 (0.55) KMT2AHTTALDH1A1CYP19A1MEN1
SCHEMBL3182658 0.77 CYP19A1 (0.62) KMT2AHTTALDH1A1CYP19A1MEN1
SCHEMBL23113418 0.74 HTT (0.42) KMT2AHTTGAACA2CA5A
SCHEMBL16829550 0.74 PTGS1 (0.46) KMT2AHTTGAAALDH1A1MEN1
SCHEMBL2310139 0.74 VCAM1 (0.65) KMT2AHTTGAACA2CA5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018104307-A1 AROMATIC SULFONAMIDE DERIVATIVES AND THEIR USE AS ANATAGON I STS OR NEGATIVE ALLOSTERIC MODULATORS OF P2X4 BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-06-14 — — WO disclosed
Send feedback